but can also suggest the replicative potential remaining in each cell.
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phenol/chloroform extraction. Then, 2 g of HinfI-digested (Tropix, Massachusetts, USA). Filters were exposed with Fuji New RX film (Fuji, Tokyo, Japan). Then the films DNA was size-fractionated by 0.8% agarose gel electrophoresis. After electrophoresis, the size-separated DNA were scanned with a Canoscan 600 (Canon, Tokyo, Japan) and the average telomere length was analyzed using NIH was transferred to a Hybond N (Amersham, UK) filter by the vacuum transfer method (BC-650; Biocraft, Tokyo, image software. Briefly, the strongest density peak was tentatively taken to be the average telomere length. Japan), 20 and crosslinked with the filter by exposure to ultraviolet light. Filters were hybridized with a telomeric probe (TTAGGG) 4 , labelled with digoxigenin according to the manufacturer's instructions (Boehringer Mannheim, Results Mannheim, Germany). Hybridization was carried out at 68°C for 12 h in the hybridization solution (5 × SSC, 0.02%
Telomere length in normal controls SDS, 0.1% sodium-lauroylsarcosine, and 1% blocking reagent). The filter was washed twice at 50°C in the washPeripheral blood mononuclear cells (PBMC) from 25 normal volunteers were studied. Mean telomere length of coning solution (0.1 × SSC, 0.1% SDS) and rinsed in the recommended blocking reagent (Boehringer Mannheim). The trols was 9.56 kb. As shown in Figure 1 , shortening of telomere length was proportional to aging. This result was hybridized probe was detected by the chemiluminescence method according to the manufacturer's recommendations similar to that demonstrated previously.
6,7,16 (Table 2 and Figure 2 ). Case 16 had the shortest telomeres (8.4 kb) after allo-HSCT, and the donor was 35 years. The difference of the mean telomere length between auto-and allo-HSCT groups may reflect the mean age of auto-HSCT and donors. The median age of auto-HSCT patients and allo-HSCT donors at HSCT were 6.1 and 16.3 years, respectively. The median follow-up periods of auto-HSCT and allo-HSCT were 3.9 and 3.4 years, respectively.
To study the effect of HSCT, patient telomeres were compared with those of the age-matched putative normal controls deduced from Figure 1 . The measured mean telomere length of auto-HSCT patients was 10.53 kb, and the mean telomere of putative controls corresponding to the age of each patient was 10.81 kb (Figure 2 ). In allo-HSCT, the examined mean telomere length of recipients was 9.92 kb, and the mean telomere length of putative controls for Figure 2 ). Case 6 had the (9.92 kb) and putative donors (10.36 kb), we next studied shortest telomere length (8.6 kb) in the auto-HSCT group.
the effect of donor age. As patients were all under 18 years She had AML (M5), and underwent auto-BMT in her third old, donors were divided into two groups of 18 years. The complete remission (CR) using stem cells harvested during average telomere length in the patients who received stem her second CR. cells from donors older or younger than 18 years was The mean telomere length of PBMCs from the patients 9.27 kb, and 10.44 kb, respectively. Since both groups were who received allo-HSCT was 9.92 kb (range, 8.4-12.0 kb) followed up for almost the same period after HSCT (3.0 years for older than 18, and 3.6 years for younger than 18), this difference was deemed to be significant (P Ͻ 0.05) (Figure 3 ).
Changes of telomere length after auto-HSCT
To verify the effect of HSCT on telomere length directly, we compared the difference of telomere length between transplanted mononuclear cells and PBMCs harvested after hematopoietic recuperation in five patients from the auto-HSCT group (Figure 4) . The follow-up period after auto-HSCT ranged from 1.0 to 4.5 years. The shortening of telomere length was within 1.0 kb compared to that of the transplanted blood cells, but this was clearly shorter than the expected telomere length affected by follow-up periods. Case 6 was transplanted with autologous bone marrow stem cells purged by 4-hydroperoxycylophosphamide (4-HC) to eradicate residual malignant cells, and her PBMC had the shortest telomeres in the auto-HSCT group. Moreover, the putative normal controls and the HSCT groups. Statistical analysis was performed using the Mann-Whitney U test. No significant difference was observed between the putative controls and the auto-HSCT group, and
Comparison of telomere length between recipients and
donor controls and allo-HSCT group. However, the allo-HSCT group had
donors in the allo-HSCT group
shorter telomeres than those of putative recipient controls (P = 0.003). The values represent the mean ±s.e. N, putative normal controls; R, putative
To address the effect of allo-HSCT directly, we compared recipient controls; D, putative donor controls; Auto, autologous HSCT group; Allo, allogeneic HSCT group; NS, not significant.
the telomere length of PBMCs in six pairs of recipients and
Discussion
In this study, we investigated the telomere length of PBMC from patients who had undergone HSCT. Several studies have demonstrated an important role of telomeres in gene stability and cell death. [15] [16] [17] Most somatic cells and hematopoietic cells have lower telomerase activity than malignant cells so that telomere length is inversely proportional to aging. 5, 6 Recently three studies revealed the existence of telomerase activity in lymphoid cells and hematopoietic stem cells. [11] [12] [13] However, Engelhart et al 11 also showed the gradual attenuation of telomerase activity in the latter half of hematopoietic stem cell culture. 11 In our study we found that telomerase activity in hematopoietic stem cells is too weak to overcome the shortening of telomere length after HSCT. In general, the shortening of telomeres may cause instability of genes, leading to a higher incidence of cancer in elderly people. Children who undergo HSCT are expected to live longer than adults who receive HSCT. So gene stability is more of a concern than with adult patients. Fortunately, telomere shortening was not significant in auto-PBSCT and allo-HSCT patients in this study. How- In our HSCT protocol, all patients received more than 2.0 × 10 8 /kg mononuclear cells, but the number of HSCs differed in each individual case. We could not study the relationship between the number of transplanted cells and the telomere length, because of differences in supportive therapy which would have influenced hematopoietic recovery. Thus, it remains unclear whether the rate of telomere shortening depends on the number of transplanted HSCs or not, because of the reduction of cell divisions.
The clinical course of case 6 was interesting. She underwent auto-BMT in her third CR using bone marrow cells harvested during her second CR and her transplanted BM cells were treated with 4-HC. Since she received cytoreductive therapy several times, her HSCs were probably forced to replicate more than those of other patients, and might have led to the shortening of telomeres.
In conclusion, our findings support that HSCT for children is safe enough with regard to telomere length, but lation, cell cycle, and telomere stability in primitive
